Seattle Genetics to Host Conference Call and Webcast Discussion of First Quarter Financial Results on April 26, 2018
April 05 2018 - 8:00AM
Business Wire
Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it
will report its first quarter financial results on Thursday, April
26, 2018 after the close of financial markets. Following the
results announcement, company management will host a conference
call and webcast discussion of the results and provide a general
corporate update. Access to the event can be obtained as
follows:
LIVE access on Thursday, April 26, 2018
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
- Telephone 800-263-0877 (domestic) or +1
646-828-8143 (international); conference ID 9171561
- Webcast available at
www.seattlegenetics.com in the Investors section
REPLAY access
- Telephone replay will be available
beginning at approximately 4:30 p.m. PT on Thursday, April 26, 2018
through 5:00 p.m. PT on Monday, April 30, 2018 by calling
888-203-1112 (domestic) or +1 719-457-0820 (international);
conference ID 9171561
- Webcast replay will be available on the
Seattle Genetics website at www.seattlegenetics.com in the
Investors section
About Seattle Genetics
Seattle Genetics is an innovative biotechnology company
dedicated to improving the lives of people with cancer through
targeted therapies. The company’s industry-leading antibody-drug
conjugate (ADC) technology harnesses the targeting ability of
antibodies to deliver cell-killing agents directly to cancer cells.
Seattle Genetics commercializes ADCETRIS® (brentuximab vedotin) for
the treatment of several types of CD30-expressing lymphomas. The
company is also advancing a robust pipeline of novel therapies for
solid tumors and blood-related cancers designed to address
significant unmet medical needs and improve treatment outcomes for
patients. More information can be found at www.seattlegenetics.com
and follow @SeattleGenetics on Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180405005333/en/
Seattle Genetics, Inc.InvestorsPeggy Pinkston,
425-527-4160ppinkston@seagen.comorMediaMonique Greer,
425-527-4641mgreer@seagen.com
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Seagen (NASDAQ:SGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024